Coagulopathy after traumatic brain injury: incidence, pathogenesis, and treatment options.

Abstract:

:Coagulopathy after traumatic brain injury (TBI) is frequent and represents a powerful predictor related to outcome and prognosis. The complex pathophysiological mechanisms of the coagulopathy of TBI are multifactorial and remain still undefined. The nature of the coagulation abnormalities differs between severe TBI and non-TBI with somatic injuries. The current hypothesis for the development of coagulopathy after TBI includes combinations of both hypo- and hypercoagulable states promoted by the magnitude and the extent of the injury resulting in a variable degree of secondary injury via subsequent ischemic and hemorrhagic lesioning. The proposed underlying mechanisms may comprise the release of tissue factor (TF), hyperfibrinolysis, shock, and hypoperfusion thus triggering the protein C pathway, disseminated intravascular coagulation, and platelet dysfunction. Hemocoagulative disorders after TBI may be amenable to treatment, and adequate and timely management may protect from secondary injury and poor outcomes. Functional assays such as viscoelastic tests may be supportive in early detection, diagnosis, and guidance of treatment. This review summarizes the current understanding with regard to frequency, pathogenesis, diagnosis, and treatment of the coagulopathy after TBI.

journal_name

Transfusion

journal_title

Transfusion

authors

Maegele M

doi

10.1111/trf.12033

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

28S-37S

eissn

0041-1132

issn

1537-2995

journal_volume

53 Suppl 1

pub_type

杂志文章,评审
  • A comprehensive program to minimize platelet outdating.

    abstract:BACKGROUND:Platelet (PLT) transfusions are essential for patients who are bleeding or have an increased risk of bleeding due to a decreased number or abnormal function of circulating PLTs. A shelf life of 5 days for PLT products presents an inventory management challenge. In 2006, greater than 10% of apheresis PLTs mad...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2010.03039.x

    authors: Fuller AK,Uglik KM,Braine HG,King KE

    更新日期:2011-07-01 00:00:00

  • Residual plasma in red blood cells and transfusion-related acute lung injury.

    abstract:BACKGROUND:Transfusion-related acute lung injury (TRALI) is the most common cause of death from blood transfusion and red blood cells (RBCs) now account for approximately 50% of these fatalities. RBCs from female donors have been implicated in large series and HLA Class II antibodies to cognate recipient antigens ident...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.12662

    authors: Weber LL,Roberts LD,Sweeney JD

    更新日期:2014-10-01 00:00:00

  • Anti-Holley (hy): characterization of another example.

    abstract::Anti-Hy, in a serum of a black man who had received multiple blood transfusions, was found to be a warm reactive and polyclonal IgG antibody which did not bind complement in vitro. 51Cr-labeled Hy-positive red blood cells in the patient showed a shortened "2-component" survival curve. Hy antigens were not detected on ...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1975.15676082238.x

    authors: Hsu TC,Jagathambal K,Sabo BH,Sawitsky A

    更新日期:1975-11-01 00:00:00

  • Histone deacetylase inhibitors suppress ABO transcription in vitro, leading to reduced expression of the antigens.

    abstract:BACKGROUND:The ABO system is of fundamental importance in the fields of transfusion and transplantation and has apparent associations with certain diseases, including cardiovascular disorders. ABO expression is reduced in the late phase of erythroid differentiation in vitro, whereas histone deacetylase inhibitors (HDAC...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.13958

    authors: Takahashi Y,Kubo R,Sano R,Nakajima T,Takahashi K,Kobayashi M,Handa H,Tsukada J,Kominato Y

    更新日期:2017-03-01 00:00:00

  • Increased risk of a positive test for antibody to hepatitis B core antigen (anti-HBC) in autologous blood donors.

    abstract::Controversy exists about the suitability of blood from autologous donors for homologous use. We compared the infectious disease test results of 426 autologous donors, designated by donor history as suitable for homologous use, to those of 86,138 volunteer donations collected over the same 5 month period. Although dono...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1988.28388219162.x

    authors: Grossman BJ,Stewart NC,Grindon AJ

    更新日期:1988-05-01 00:00:00

  • Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia.

    abstract::A 24-year-old, blood-group O Polynesian woman with multiple red blood cell antibodies received a group A, HLA-compatible, sex-matched bone marrow transplantation as treatment for severe aplastic anemia. High retransplantation titers of ABO isohemagglutinins were successfully reduced by repeated plasmaphereses. Despite...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1982.22182154221.x

    authors: Ockelford PA,Hill RS,Nelson L,Blacklock HA,Woodfield DG,Matthews JR

    更新日期:1982-01-01 00:00:00

  • Center error reduction by recheck of blood type.

    abstract::Our computer system currently stores donor blood types for seven years and checks typing of all repeat donors against these files. In a recent three-month period (42,500 units), five discrepancies were found--two representing current error. Retrospective analysis of 18 errors made over the last three years showed that...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1981.21281178157.x

    authors: Grindon AJ,Liles BA

    更新日期:1981-03-01 00:00:00

  • Peripartum hyperhemolysis prophylaxis and management in sickle cell disease: A case report and narrative review.

    abstract:BACKGROUND:Sickle cell disease (SCD) is associated with hematologic complications including delayed hemolytic transfusion reactions (DHTRs) and pregnancy-related morbidity and mortality. Hyperhemolysis syndrome (HS) is the most severe form of DHTR in patients with SCD, in which both transfused and native red blood cell...

    journal_title:Transfusion

    pub_type:

    doi:10.1111/trf.16003

    authors: Vasanthamohan L,Choo S,Marshall T,Symons YT,Matsui D,Eastabrook G,Solh Z

    更新日期:2020-08-26 00:00:00

  • Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.

    abstract:BACKGROUND:The successful mobilization and collection of hematopoietic stem cells are dependent on a number of clinical factors such as previous chemotherapy and disease stage. The aim of this retrospective study was to determine whether the effectiveness of mobilization and collection is an independent prognostic fact...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2007.01448.x

    authors: Wang S,Nademanee A,Qian D,Dagis A,Park HS,Fridey J,Smith E,Snyder D,Somlo G,Stein A,Rosenthal J,Falk P,Kogut N,Palmer J,Gaal K,Kim Y,Bhatia R,Yuan S,Kay C,Weiss L,Forman S

    更新日期:2007-12-01 00:00:00

  • Preparation of white cell-reduced platelet concentrates from whole blood during component preparation.

    abstract::This article introduces a new method of component preparation that is capable of producing white cell (WBC)-reduced platelet concentrates (PCs) from whole blood. Whole blood is separated into packed red cells (RBCs) and platelet-rich plasma (PRP) by centrifugation, and the PRP is expressed through a newly designed WBC...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1991.31691306254.x

    authors: Dzik WH,Cusack WF,Gacek MJ

    更新日期:1991-07-01 00:00:00

  • Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016.

    abstract::The US Food and Drug Administration (FDA) held a workshop on red blood cell (RBC) product regulatory science on October 6 and 7, 2016, at the Natcher Conference Center on the National Institutes of Health (NIH) Campus in Bethesda, Maryland. The workshop was supported by the National Heart, Lung, and Blood Institute, N...

    journal_title:Transfusion

    pub_type:

    doi:10.1111/trf.14435

    authors: Vostal JG,Buehler PW,Gelderman MP,Alayash AI,Doctor A,Zimring JC,Glynn SA,Hess JR,Klein H,Acker JP,Spinella PC,D'Alessandro A,Palsson B,Raife TJ,Busch MP,McMahon TJ,Intaglietta M,Swartz HM,Dubick MA,Cardin S,Patel

    更新日期:2018-01-01 00:00:00

  • Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study.

    abstract::Clinical and serological data on 1435 Italian thalassemia major patients were collected during a cooperative study involving 19 centers in 10 regions. The main findings were as follows: 18 percent of the patients were under 6 years of age, 63 percent between 6 and 15, and 19 percent over 15. Forty-one percent had unde...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1985.25285169198.x

    authors: Sirchia G,Zanella A,Parravicini A,Morelati F,Rebulla P,Masera G

    更新日期:1985-03-01 00:00:00

  • Adequacy of physician documentation and correlation with assessment of transfusion appropriateness: a follow-up study in the setting of prospective audits and patient blood management.

    abstract:BACKGROUND:A previous study in our hospitals correlated suboptimal documentation and failure to justify transfusions. In light of implemented blood-conservation strategies, including patient blood management (PBM) and prospective audits (PAs), we performed a follow-up study. STUDY DESIGN AND METHODS:We reviewed prospe...

    journal_title:Transfusion

    pub_type: 杂志文章,多中心研究

    doi:10.1111/trf.13917

    authors: Madrigal E,Prajapati S,Avadhani V,Annen K,Friedman MT

    更新日期:2017-02-01 00:00:00

  • Evaluation of a lateral flow-based technology card for blood typing using a simplified protocol in a model of extreme blood sampling conditions.

    abstract:BACKGROUND:Life-threatening situations requiring blood transfusion under extreme conditions or in remote and austere locations, such as the battlefield or in traffic accidents, would benefit from reliable blood typing practices that are easily understood by a nonscientist or nonlaboratory technician and provide quick r...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.14420

    authors: Clavier B,Pouget T,Sailliol A

    更新日期:2018-02-01 00:00:00

  • Prospective surveillance of D- recipients of D+ apheresis platelets: alloimmunization against D is not detected.

    abstract:BACKGROUND:Recent retrospective studies indicate that D- recipients of D+ apheresis platelets (PLTs) are not alloimmunized to D. Our hospital policy is to offer RhIG to D- women of childbearing age who received D+ apheresis PLTs but not to other D- recipients of D+ apheresis PLTs. We instituted prospective surveillance...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.12972

    authors: Weinstein R,Simard A,Ferschke J,Vauthrin M,Bailey JA,Greene M

    更新日期:2015-06-01 00:00:00

  • Risk behavior in Norwegian blood donors.

    abstract:BACKGROUND:Blood banks ensure the safety of blood components by testing them for a set of known infectious agents and by careful selection of donors based on a self-administered questionnaire and an interview. The purpose of this study is to describe the risk behavior for sexually transmitted diseases in Norwegian bloo...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.2001.41121480.x

    authors: Stigum H,Bosnes V,Ørjasaeter H,Heier HE,Magnus P

    更新日期:2001-12-01 00:00:00

  • Large scale preparation of leukocyte concentrates and further purification of lymphocytes and granulocytes with the IBM 2991 cell processor.

    abstract::A procedure is described for the large-scale production of pure suspensions of human lymphocytes and granulocytes. Platelet-poor buffy-coats, obtained by centrifugation of six units of ABO-compatible ACD blood, were pooled and centrifuged again, resulting in a crude leukocyte concentrate containing approximately 60 pe...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1977.17578014593.x

    authors: de la Rivière AB,Verhoef-Karssen PR,de Wit JJ,Loos JA,Prins HK

    更新日期:1977-09-01 00:00:00

  • The influence of irradiation on stored platelets.

    abstract::Platelet concentrates intended for transfusion to immunosuppressed patients are irradiated to minimize transfusion-induced graft-versus-host disease. Because few reports describe how irradiation influences stored platelets, the authors studied whether 5000 rad of gamma irradiation, the maximum dose currently used clin...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1986.26587020124.x

    authors: Moroff G,George VM,Siegl AM,Luban NL

    更新日期:1986-09-01 00:00:00

  • Cesarean section due to fetal distress increases the number of stem cells in umbilical cord blood.

    abstract:BACKGROUND:Umbilical cord blood (UCB) can be used as hematopoietic stem cell source for transplantation. The success of a transplantation is highly correlated with the number of total nucleated cells (TNCs) and CD34+ cells in the UCB. Certain obstetric factors increase the yield of stem cells in the UCB. It is necessar...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2007.01617.x

    authors: Manegold G,Meyer-Monard S,Tichelli A,Pauli D,Holzgreve W,Troeger C

    更新日期:2008-05-01 00:00:00

  • Hemolytic transfusion reaction due to anti-IH.

    abstract:BACKGROUND:Anti-IH is usually a clinically insignificant antibody that may complicate a serologic workup. However, it can occasionally cause hemolysis. We report a rare case of acute hemolysis caused by anti-IH. CASE REPORT:A 60-year-old man with a long history of chronic myelomonocytic leukemia and anemia, blood grou...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2011.03209.x

    authors: Irani MS,Richards C

    更新日期:2011-12-01 00:00:00

  • Quantity, quality, and functionality of peripheral blood cells derived from residual blood of different apheresis kits.

    abstract:BACKGROUND:Research with primary human white blood cell (WBC) subpopulations requires high quantity, quality, and functionality of peripheral blood mononuclear cells (PBMCs) as a source to further characterize cellular subpopulations such as T and B lymphocytes, monocytes, or natural killer cells. Apart from buffy coat...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.14616

    authors: Knörck A,Marx S,Friedmann KS,Zöphel S,Lieblang L,Hässig C,Müller I,Pilch J,Sester U,Hoth M,Eichler H,Sester M,Schwarz EC

    更新日期:2018-06-01 00:00:00

  • Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.

    abstract:BACKGROUND:We present an analysis of the first 2 years of hepatitis B virus (HBV) nucleic acid testing (NAT) of the Australian donor population. STUDY DESIGN AND METHODS:Between July 5, 2010, and July 4, 2012, all blood donations were screened for HBV DNA and hepatitis B surface antigen (HBsAg). Donors who tested HBsA...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.12556

    authors: Kiely P,Margaritis AR,Seed CR,Yang H,Australian Red Cross Blood Service NAT Study Group.

    更新日期:2014-08-01 00:00:00

  • Novel multiple swab method enables high efficiency in SARS-CoV-2 screenings without loss of sensitivity for screening of a complete population.

    abstract:BACKGROUND:In the pandemic, testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by real-time polymerase chain reaction is one of the pillars on which countermeasures are based. Factors limiting the output of laboratories interfere with the effectiveness of public health measures. Conserving reagent...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.15973

    authors: Schmidt M,Hoehl S,Berger A,Zeichhardt H,Hourfar K,Ciesek S,Seifried E

    更新日期:2020-07-06 00:00:00

  • Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.

    abstract:BACKGROUND:Transplant-associated thrombotic microangiopathy (TA-TMA) is a multifactorial disorder, which occurs as a result of treatment-related endothelial injury and underlying disease process after hematopoietic stem cell transplantation (HSCT). The reported incidence of TA-TMA after HSCT is 0% to 74% and has shown ...

    journal_title:Transfusion

    pub_type: 杂志文章,评审

    doi:10.1111/trf.12859

    authors: Kim SS,Patel M,Yum K,Keyzner A

    更新日期:2015-02-01 00:00:00

  • Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation.

    abstract:BACKGROUND:Platelets (PLTs) contain purinergic receptors for ATP (P2X1) and ADP (P2Y1 and P2Y12) that rapidly desensitize upon stimulation with these nucleotides. In vivo, this is antagonized by ectonucleotidases on the surface of endothelial cells and white blood cells (WBCs). The receptor desensitization of ATP- and ...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2006.00837.x

    authors: Cauwenberghs S,Feijge MA,Hageman G,Hoylaerts M,Akkerman JW,Curvers J,Heemskerk JW

    更新日期:2006-06-01 00:00:00

  • Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution.

    abstract:BACKGROUND:Previously, we evaluated the Mirasol pathogen reduction technology (PRT) system on platelet (PLT) function before resuspension. We now evaluated this system in the presence of PLT additive solution (PAS). STUDY DESIGN AND METHODS:Double-dose PLTs (n = 15) were generated using a commercially available aphere...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2011.03323.x

    authors: Picker SM,Tauszig ME,Gathof BS

    更新日期:2012-03-01 00:00:00

  • Single hospital experience of TRALI.

    abstract:BACKGROUND:TRALI is a serious adverse effect of blood transfusion. There is evidence that the condition is underrecognized and underreported. STUDY DESIGN AND METHODS:This study was an observational study carried out in a single hospital. RESULTS:Eleven cases of TRALI were recognized over 12 years. In 10 cases the im...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.2003.00466.x

    authors: Wallis JP,Lubenko A,Wells AW,Chapman CE

    更新日期:2003-08-01 00:00:00

  • Bacterial screening of apheresis platelets with a rapid test: a 113-month single center experience.

    abstract:BACKGROUND:The 2016 Food and Drug Administration draft guidance describes the use of a rapid test (RT) to enhance platelet transfusion safety and availability. This study reports a 113-month experience of screening of apheresis platelets (APs) by RT. STUDY DESIGN AND METHODS:From July 2008 to October 2015, all APs und...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/trf.14629

    authors: Ruby KN,Thomasson RR,Szczepiorkowski ZM,Dunbar NM

    更新日期:2018-07-01 00:00:00

  • Comparison of plateletapheresis with two continuous-flow cell separators using identical donors.

    abstract::Each of 20 donors underwent plateletapheresis on both the CS-3000 (Fenwal) and the 2997 (IBM) blood cell separators. The same operator performed both procedures and conducted all product studies for each donor. Platelet collection efficiency was significantly greater with the 2997 (81%) than the CS-3000 (60%) (p less ...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1046/j.1537-2995.1985.25485273811.x

    authors: Mintz PD

    更新日期:1985-07-01 00:00:00

  • Antibodies to co-trimoxazole (trimethoprim and/or sulfamethoxazole) related to the presence of the drug in a commercial low-ionic-strength solution.

    abstract:BACKGROUND:Drug-dependent antibodies have been associated with approximately 10% of acquired immune hemolytic anemia cases. These antibodies are a rare cause of interference in pretransfusion red blood cell (RBC) serologic testing. The aim of this work was to report three cases of subjects developing antibodies against...

    journal_title:Transfusion

    pub_type: 杂志文章

    doi:10.1111/j.1537-2995.2011.03327.x

    authors: Pham BN,Gien D,Bensaad F,Babinet J,Dubeaux I,Rouger P,Le Pennec PY

    更新日期:2012-04-01 00:00:00